Le produit a bien été ajouté au panier.

discount label
5Fam-CRGDK-OH
Vue en 3D

Biosynth logo

5Fam-CRGDK-OH

Ref. 3D-PP45141

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mardi 3 décembre 2024

Informations sur le produit

Nom :
5Fam-CRGDK-OH
Synonymes :
  • 5Fam-Cys-Arg-Gly-Asp-Lys-OH
Description :

Peptide 5Fam-CRGDK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using 5Fam-CRGDK-OH include the following: Internalizing RGD, a great motif for targeted peptide and protein delivery: a review article Z Davoodi, F Shafiee - Drug Delivery and Translational Research, 2022 - Springerhttps://link.springer.com/article/10.1007/s13346-022-01116-7 Tumor-targeting peptide for redox-responsive Pt prodrug and gene codelivery and synergistic cancer chemotherapy Y Bai, Z Li, L Liu, T Sun, X Fan, T Wang - ACS Applied Bio , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsabm.9b00065 Increased antitumor activity of tumor-specific peptide modified thymopentin X Lao, B Li, M Liu, J Chen, X Gao, H Zheng - Biochimie, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0300908414002624 Does ligand-receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL? WQ Zhang, KF Yu, T Zhong , LM Luo, R Du - Journal of drug , 2015 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.3109/1061186X.2015.1034279 Peptide-functionalized delivery vehicles for enhanced cancer therapy SY Tang, H Wei, CY Yu - International Journal of Pharmaceutics, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517320311261 Peptide-mediated cancer targeting of nanoconjugates S Raha , T Paunesku - Wiley Interdisciplinary , 2011 - Wiley Online Libraryhttps://wires.onlinelibrary.wiley.com/doi/abs/10.1002/wnan.121 Neuropilin-1 Binding Peptide as Fusion to Diphtheria Toxin Induces Apoptosis in Non-small Cell Lung Cancer Cell Line S Eghtedari, M Behdani - Current , 2024 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2024/00000030/00000017/art00003 Developments in tumor targeting and internalizing peptides RIC Padanha - 2017 - repositorio.ul.pthttps://repositorio.ul.pt/handle/10451/36085 Peptide-based nanoprobes for molecular imaging and disease diagnostics P Zhang , Y Cui, CF Anderson , C Zhang, Y Li - Chemical Society , 2018 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2018/cs/c7cs00793k Homing peptides for cancer therapy P Lingasamy , T Teesalu - Bio-nanomedicine for cancer therapy, 2021 - Springerhttps://link.springer.com/chapter/10.1007/978-3-030-58174-9_2 Tumor penetrating peptide-functionalized tenascin-C antibody for glioblastoma targeting P Lingasamy , AH Laarmann - Current cancer drug , 2021 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ccdt/2021/00000021/00000001/art00006 A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer MV Cano-Cortes , SA Navarro-Marchal - , Biology and Medicine, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1549963419302047 Peptide-modified nanoparticles for tumor targeting and molecular imaging L Lu, Q Zhang, Z Wang, L Gao - Current Medicinal , 2021 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2021/00000028/00000031/art00009 De Novo Design of a Tumor-Penetrating Peptide L Alberici, L Roth, KN Sugahara, L Agemy - Cancer research, 2013 - AACRhttps://aacrjournals.org/cancerres/article-abstract/73/2/804/590737 Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32 L Agemy, VR Kotamraju, D Friedmann-Morvinski - Molecular Therapy, 2013 - cell.comhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)30945-5 Tissue-penetrating delivery of compounds and nanoparticles into tumors KN Sugahara, T Teesalu , PP Karmali, VR Kotamraju - Cancer cell, 2009 - cell.comhttps://www.cell.com/cancer-cell/pdf/S1535-6108(09)00382-1.pdf A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis KN Sugahara, P Scodeller , GB Braun - Journal of Controlled , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365915006161 Cell-Penetrating Peptide-Conjugated BF2-Oxasmaragdyrins as NIRF Imaging and Photothermal Agents K Laxman , BPK Reddy , A Robinson - , 2020 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cmdc.202000401 Use of Chitosan from Southern King Crab to Develop Films Functionalized with RGD Peptides for Potential Tissue Engineering Applications JC Forero , K Carvajal, F Guzman, C Acevedo, N Osses - Biomimetics, 2023 - mdpi.comhttps://www.mdpi.com/2313-7673/8/3/323 Integrin-targeting peptides for the design of functional cell-responsive biomaterials J Zhao, F Santino, D Giacomini, L Gentilucci - Biomedicines, 2020 - mdpi.comhttps://www.mdpi.com/2227-9059/8/9/307 Theranostic iRGD peptide containing cisplatin prodrug: Dual-cargo tumor penetration for improved imaging and therapy HJ Cho , SJ Park, YS Lee , S Kim - Journal of controlled release, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365919301269 Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging HJ Cho , SJ Lee, SJ Park, CH Paik, SM Lee - Journal of Controlled , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365916304096 A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity HB Pang , GB Braun , ZG She , VR Kotamraju - Journal of Controlled , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365913009486 iRGD: a promising peptide for cancer imaging and a potential therapeutic agent for various cancers H Zuo - Journal of Oncology, 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2019/9367845 Peptide-decorated polymeric nanomedicines for precision cancer therapy H Sun , Y Dong, J Feijen , Z Zhong - Journal of controlled release, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365918305686 Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery H Song, J Zhang, W Wang , P Huang, Y Zhang - Colloids and Surfaces B , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0927776515301995 Amphipathic tail-anchoring peptide is a promising therapeutic agent for prostate cancer treatment G De, JK Ko , T Tan, H Zhu , H Li , J Ma - Oncotarget, 2014 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202157/ CRGDK-functionalized PAMAM-based drug-delivery system with high permeability D Liu, C Wang, J Yang, Y An, R Yang, G Teng - ACS omega, 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.0c00202 Targeted modification of the cationic anticancer peptide HPRP-A1 with iRGD to improve specificity, penetration, and tumor-tissue accumulation C Hu, Y Huang, Y Chen - Molecular Pharmaceutics, 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.8b00854 Nrp-1 receptor targeting peptide-functionalized TPGS micellar nanosystems to deliver 10-hydroxycampothecin for enhanced cancer chemotherapy A Mozhi , I Ahmad , QM Kaleem, RG Tuguntaev - International journal of , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517318303880 Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment A Kumar , H Ma, X Zhang , K Huang, S Jin , J Liu , T Wei - Biomaterials, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961211012622 Peptide-based strategies for targeted tumor treatment and imaging A Ayo, P Laakkonen - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/4/481

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP45141 5Fam-CRGDK-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".